Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1987 Feb;50(2):134–139. doi: 10.1136/jnnp.50.2.134

Occurrence of multiple sclerosis in the north and south of New Zealand.

D C Skegg, P A Corwin, R S Craven, J A Malloch, M Pollock
PMCID: PMC1031483  PMID: 3494813

Abstract

An impression that multiple sclerosis is commoner in southern parts of New Zealand than in the north has never been tested rigorously. Identical methods were used to determine the prevalence and incidence of multiple sclerosis in two regions: the Waikato (in the North Island) and Otago and Southland (in the South Island). No cases were found in Maoris, while the expected number was 11.7. The prevalence rate of multiple sclerosis (excluding possible cases) in non-Maoris was 24 per 100,000 in the northern region and 69 per 100,000 in the south. The incidence rate was also more than twice as high in the southern region. These findings are considered in relation to genetic and environmental hypotheses about the aetiology of multiple sclerosis.

Full text

PDF
134

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ACHESON E. D. Multiple sclerosis in British Commonwealth countries in the Southern Hemisphere. Br J Prev Soc Med. 1961 Jul;15:118–125. doi: 10.1136/jech.15.3.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Acheson E. D. Epidemiology of multiple sclerosis. Br Med Bull. 1977 Jan;33(1):9–14. doi: 10.1093/oxfordjournals.bmb.a071407. [DOI] [PubMed] [Google Scholar]
  3. Craelius W. Comparative epidemiology of multiple sclerosis and dental caries. J Epidemiol Community Health. 1978 Sep;32(3):155–165. doi: 10.1136/jech.32.3.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dean G. Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa. Br Med J. 1967 Jun 17;2(5554):724–730. doi: 10.1136/bmj.2.5554.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dick G. President's address. The etiology of multiple sclerosis. Proc R Soc Med. 1976 Aug;69(8):611–615. [PMC free article] [PubMed] [Google Scholar]
  6. Francis D. A., Batchelor J. R., McDonald W. I., Hern J. E., Downie A. W. Multiple sclerosis and HLA DQw1. Lancet. 1986 Jan 25;1(8474):211–211. doi: 10.1016/s0140-6736(86)90684-7. [DOI] [PubMed] [Google Scholar]
  7. Kurtzke J. F. A reassessment of the distribution of multiple sclerosis. Part one. Acta Neurol Scand. 1975 Feb;51(2):110–136. doi: 10.1111/j.1600-0404.1975.tb01364.x. [DOI] [PubMed] [Google Scholar]
  8. Kurtzke J. F. Geographic distribution of multiple sclerosis: An update with special reference to Europe and the Mediterranean region. Acta Neurol Scand. 1980 Aug;62(2):65–80. doi: 10.1111/j.1600-0404.1980.tb03006.x. [DOI] [PubMed] [Google Scholar]
  9. MILLER H., RIDLEY A., SCHAPIRA K. Multiple sclerosis. A note on social incidence. Br Med J. 1960 Jul 30;2(5195):343–345. doi: 10.1136/bmj.2.5195.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mazzella G. L., Sinforiani E., Savoldi F., Allegrini M., Lanzola E., Scelsi R. Blood cells glutathione peroxidase activity and selenium in multiple sclerosis. Eur Neurol. 1983;22(6):442–446. doi: 10.1159/000115600. [DOI] [PubMed] [Google Scholar]
  11. McCall M. G., Brereton T. L., Dawson A., Millingen K., Sutherland J. M., Acheson E. D. Frequency of multiple sclerosis in three Australian cities--Perth, Newcastle, and Hobart. J Neurol Neurosurg Psychiatry. 1968 Feb;31(1):1–9. doi: 10.1136/jnnp.31.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McDonald W. I. Multiple sclerosis: the present position. Acta Neurol Scand. 1983 Aug;68(2):65–76. doi: 10.1111/j.1600-0404.1983.tb04819.x. [DOI] [PubMed] [Google Scholar]
  13. POSKANZER D. C., SCHAPIRA K., MILLER H. MULTIPLE SCLEROSIS AND POLIOMYELITIS. Lancet. 1963 Nov 2;2(7314):917–921. doi: 10.1016/s0140-6736(63)90624-x. [DOI] [PubMed] [Google Scholar]
  14. Shepherd D. I., Downie A. W. A further prevalence study of multiple sclerosis in north-east Scotland. J Neurol Neurosurg Psychiatry. 1980 Apr;43(4):310–315. doi: 10.1136/jnnp.43.4.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Smith A. H., Pearce N. E. Determinants of differences in mortality between New Zealand Maoris and non-Maoris aged 15-64. N Z Med J. 1984 Feb 22;97(750):101–108. [PubMed] [Google Scholar]
  16. Spielman R. S., Nathanson N. The genetics of susceptibility to multiple sclerosis. Epidemiol Rev. 1982;4:45–65. doi: 10.1093/oxfordjournals.epirev.a036251. [DOI] [PubMed] [Google Scholar]
  17. Stazio A., Paddison R. M., Kurland L. T. Multiple sclerosis in New Orleans, Louisiana, and Winnipeg, Manitoba, Canada: follow-up of a previous survey in New Orleans, and comparison between the patient populations in the two communities. J Chronic Dis. 1967 May;20(5):311–332. doi: 10.1016/0021-9681(67)90059-8. [DOI] [PubMed] [Google Scholar]
  18. Thomson C. D., Robinson M. F. Selenium in human health and disease with emphasis on those aspects peculiar to New Zealand. Am J Clin Nutr. 1980 Feb;33(2):303–323. doi: 10.1093/ajcn/33.2.303. [DOI] [PubMed] [Google Scholar]
  19. Wolfgram F. Similar geographical distribution of multiple sclerosis and cancer of the colon. Acta Neurol Scand. 1975 Oct;52(4):294–302. doi: 10.1111/j.1600-0404.1975.tb05825.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES